Cost-of-illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden-A population-based register-linkage study-Reference-Cited by-同舟云学术

Cost-of-illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden-A population-based register-linkage study

Published:2019-01-16 Issue:2 Volume:28 Page:e12983
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Lesén Eva¹,Granfeldt Daniel²,Houchard Aude³,Berthon Anthony³,Dinet Jérôme³,Gabriel Sylvie³,Björstad Åse²,Björholt Ingela²,Elf Anna-Karin⁴,Johanson Viktor⁴

Affiliation:

1. Nordic Health Economics; Gothenburg Sweden

2. PharmaLex Sweden, formerly Nordic Health Economics; Gothenburg Sweden

3. Ipsen; Boulogne-Billancourt France

4. Department of Surgery; Sahlgrenska University Hospital; Gothenburg Sweden

Funder

Ipsen

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12983/fullpdf

Reference16 articles.

1. Midgut neuroendocrine tumours with liver metastases: Results of the UKINETS study;Ahmed;Endocrine-Related Cancer,2009

2. The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: A Swedish sub-study to the HOPE study;Bjorholt;Journal of Internal Medicine,2002

3. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality of life and costs;Carrato;Journal of Gastrointestinal Cancer,2015

4. Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: A systematic review;Chau;European Journal of Cancer Care,2013

5. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncology,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consistency between the National Patient Register and the Swedish Cancer Register;Pharmacoepidemiology and Drug Safety;2024-03-21

2. Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms;JCO Oncology Practice;2023-12-14

3. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline;Journal of Clinical Oncology;2023-11-10

4. Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database;Clinics and Research in Hepatology and Gastroenterology;2023-08

5. Comparison of long-term survival between surgery-plus-chemotherapy and surgery- plus-chemoradiotherapy for high-grade gastrointestinal neuroendocrine tumors: a SEER-based study;2023-03-30